Here's what happened in life sciences last week 💊📰

The Theranos story, China extends drug patent protection, scientists to grow mini-brains and other interesting reads from the past week.

Noteworthy 📰

  • Trump wants to increase competition for medicines, cut list prices and reduce patients’ out-of-pocket costs. Link

  • China to extend drug patent protection to 25 years, up from 20. Link

  • FDA to call out brand name drug companies that block generics. Link

  • Trans fats should be eliminated worldwide by 2023, W.H.O. says. Link

  • Pfizer's biosimilar of Amgen, J&J's anemia treatments gets FDA nod. Link

Digital Health 💻

  • How data analytics and AI are changing the pharma industry. Link

  • New technology promises to speed critical treatment for strokes. Link

  • This startup wants to be Airbnb for gene sequencers. Link

Research 🔬

  • Cause of POCD, the primary reason behind female infertility. Link

  • Bacteria therapy shows promise for eczema. Link

Perspective and Opinions 📢

  • What Trump should actually do about the high cost of drugs. Link

  • The European biosimilars landscape: What to expect in the year ahead. Link

  • Blood, sweat and tears in biotech — the Theranos story. Link

  • As D.I.Y. gene editing gains popularity, ‘someone is going to get hurt’. Link

Interesting 🤔

  • Scientists to grow 'mini-brains' using Neanderthal DNA. Link

  • Easing migraines with an earplug. Link

Deep Dive 👓

A look at the future of customized medicine. Link

Did You Know? ❓

Startups 💰

  • The new Hong Kong company will focus on preventive & therapeutic vaccines for Asia. Link

  • Tel Aviv VC fund aMoon gets $250M from Credit Suisse, emerges as a top player in Israel. Link

  • Asymchem starts a fund to bring novel western drugs to China. Link

Our Digital Times 😃